Baxter International Inc. (BAX) Stock

Baxter International Inc., operating through its subsidiaries, is a global leader in the development and provision of a wide array of healthcare products essential for medical treatments worldwide. The company's comprehensive portfolio includes innovative solutions in peritoneal and hemodialysis, along with additional dialysis therapies and services. Baxter also specializes in intravenous therapies, infusion pumps, and drug reconstitution devices crucial for administering medications effectively.

Moreover, Baxter excels in offering advanced medical technologies such as inhaled anesthesia products, critical care equipment, and pharmacy compounding services. Its product lineup extends to parenteral nutrition therapies, biological products used in surgical procedures, and medical devices designed for hemostasis, tissue sealing, and adhesion prevention. The company is particularly focused on continuous renal replacement therapies and other organ support solutions tailored for intensive care units.

Baxter International is committed to enhancing patient care through connected care solutions, including devices, software, and integration technologies that enable efficient monitoring and diagnosis of various illnesses. With a robust global presence spanning approximately 100 countries, Baxter serves hospitals, dialysis centers, nursing homes, rehabilitation facilities, and patients receiving treatment at home under medical supervision. Founded in 1931 and headquartered in Deerfield, Illinois, Baxter continues to pioneer advancements in healthcare technology and expand its reach through strategic partnerships and collaborations aimed at advancing medical treatments and improving patient outcomes.